In DLD1 and HCT116 CRC cell lines engineered to express an exogenous β-catenin-responsive, luciferase-based reporter, CDK8 was identified as being necessary for β-catenin-driven malignancy from a focused shRNA screen51. This evidence concerns the gene CDK8 and colorectal carcinoma.